Cyclin-dependent kinase inhibitor protein
A cyclin-dependent kinase inhibitor protein (also known as CKIs, CDIs, or CDKIs) is a protein which inhibits the enzyme cyclin-dependent kinase (CDK) and Cyclin activity by stopping the cell cycle if there are unfavorable conditions, therefore, acting as tumor suppressors. Cell cycle progression is stopped by Cyclin-dependent kinase inhibitor protein at the G1 phase. CKIs are vital proteins within the control system that point out whether the process of DNA synthesis, mitosis, and cytokines control one another. If a malfunction prevents the successful completion of DNA synthesis during the G1 phase, a signal is sent to delay or stop the progression to the S phase. Cyclin-dependent kinase inhibitor proteins are essential in the regulation of the cell cycle. If cell mutations surpass the cell cycle checkpoints during cell cycle regulation, it can result in various types of cancer.
Cyclin-dependent kinase inhibitor | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. | |||||||||||
Identifiers | |||||||||||
Symbol | CDI | ||||||||||
Pfam | PF02234 | ||||||||||
InterPro | IPR003175 | ||||||||||
SCOP2 | 1jsu / SCOPe / SUPFAM | ||||||||||
|